Lataa...
Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial
BACKGROUND: Improved drug regimens are needed to accelerate elimination of lymphatic filariasis in Africa. This study determined whether a single co-administered dose of ivermectin plus diethylcarbamazine plus albendazole [IDA] is noninferior to standard 3 annual doses of ivermectin plus albendazole...
Tallennettuna:
| Julkaisussa: | Clin Infect Dis |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583415/ https://ncbi.nlm.nih.gov/pubmed/31641754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1050 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|